Am. J. Respir. Cell Mol. Biol., Volume 24, Number 4, April, 2001 368-375

Interleukin-9 Reduces Lung Fibrosis and Type 2 Immune Polarization Induced by Silica Particles in a Murine Model

Mohammed Arras, François Huaux, Anne Vink, Monique Delos, Jean-Paul Coutelier, Marie-Christine Many, Virginie Barbarin, Jean-Christophe Renauld, and Dominique Lison

Industrial Toxicology and Occupational Medicine Unit, Faculty of Medicine; Laboratory of Pathology, University Hospital of Mont Godinne; Laboratory of Histology, Faculty of Medicine; and Unit of Experimental Medicine and Ludwig Institute for Cancer Research, Faculty of Medicine, Université Catholique de Louvain, Brussels, Belgium

We examined the effect of interleukin (IL)-9, a cytokine active on B and T lymphocytes and associated with bronchial asthma, on the development of lung fibrosis induced by crystalline silica particles. Therefore, we compared the response to silica (1 and 5 mg/animal, intratracheally) in transgenic mice that constitutively express high levels of IL-9 (Tg5) and their wild-type counterparts (FVB). At 2 and 4 mo after treatment with silica, histologic examination and measurement of lung hydroxyproline content showed that the severity of fibrosis was significantly less important in Tg5 mice than in their wild-type counterparts. Intraperitoneal injection of IL-9 in C57BL/6 mice also reduced the amplitude of silica-induced lung fibrosis. The reduction of lung fibrosis by IL-9 was associated with a significant expansion of the B-lymphocyte population, both in bronchoalveolar lavage (BAL) and in the pulmonary parenchyma. In wild-type animals, silica-induced fibrosis correlated with markers of a T helper 2-like response such as upregulation of IL-4 levels in lung tissue and an increased immunoglobulin (Ig) G1/IgG2a ratio in BAL. Immunohistochemical studies demonstrated that the upregulation of IL-4 associated with the development of fibrosis was mainly localized in inflammatory alveolar macrophages. In transgenic mice, the level of IL-4 in lung homogenates was not significantly affected by silica treatment, and a reduced IgG1/IgG2a ratio was observed upon treatment with silica. The levels of interferon- were significantly decreased after silica treatment in both strains. Together, these observations point to an antifibrotic effect of IL-9 in pulmonary fibrosis associated with a limitation of the type 2 polarization which accompanies lung fibrosis.

This article has been cited by other articles:

				T. Sato, T. Shimosato, W. G. Alvord, and D. M. Klinman Suppressive Oligodeoxynucleotides Inhibit Silica-Induced Pulmonary Inflammation J. Immunol., June 1, 2008; 180(11): 7648 - 7654. [Abstract] [Full Text] [PDF]

				S. van den Brule, J. Heymans, X. Havaux, J.-C. Renauld, D. Lison, F. Huaux, and O. Denis Profibrotic Effect of IL-9 Overexpression in a Model of Airway Remodeling Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 202 - 209. [Abstract] [Full Text] [PDF]

				V. Steenwinckel, J. Louahed, C. Orabona, F. Huaux, G. Warnier, A. McKenzie, D. Lison, R. Levitt, and J.-C. Renauld IL-13 Mediates In Vivo IL-9 Activities on Lung Epithelial Cells but Not on Hematopoietic Cells J. Immunol., March 1, 2007; 178(5): 3244 - 3251. [Abstract] [Full Text] [PDF]

				P. Misson, F. Brombacher, M. Delos, D. Lison, and F. Huaux Type 2 immune response associated with silicosis is not instrumental in the development of the disease Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L107 - L113. [Abstract] [Full Text] [PDF]

				M. Arras, J. Louahed, V. Simoen, V. Barbarin, P. Misson, S. van den Brule, M. Delos, L. Knoops, J.-C. Renauld, D. Lison, et al. B Lymphocytes Are Critical for Lung Fibrosis Control and Prostaglandin E2 Regulation in IL-9 Transgenic Mice Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 573 - 580. [Abstract] [Full Text] [PDF]

				M. Arras, J. Louahed, J.-F. Heilier, M. Delos, F. Brombacher, J.-C. Renauld, D. Lison, and F. Huaux IL-9 Protects against Bleomycin-Induced Lung Injury: Involvement of Prostaglandins Am. J. Pathol., January 1, 2005; 166(1): 107 - 115. [Abstract] [Full Text] [PDF]

				P. Misson, S. van den Brule, V. Barbarin, D. Lison, and F. Huaux Markers of macrophage differentiation in experimental silicosis J. Leukoc. Biol., November 1, 2004; 76(5): 926 - 932. [Abstract] [Full Text] [PDF]

				M. W. Wynes and D. W. H. Riches Induction of Macrophage Insulin-Like Growth Factor-I Expression by the Th2 Cytokines IL-4 and IL-13 J. Immunol., October 1, 2003; 171(7): 3550 - 3559. [Abstract] [Full Text] [PDF]

				F. Huaux, T. Liu, B. McGarry, M. Ullenbruch, and S. H. Phan Dual Roles of IL-4 in Lung Injury and Fibrosis J. Immunol., February 15, 2003; 170(4): 2083 - 2092. [Abstract] [Full Text] [PDF]

				C. Pilette, Y. Ouadrhiri, J. Van Snick, J-C. Renauld, P. Staquet, J-P. Vaerman, and Y. Sibille Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9 Eur. Respir. J., November 1, 2002; 20(5): 1198 - 1205. [Abstract] [Full Text] [PDF]

				C. Pilette, Y. Ouadrhiri, J. Van Snick, J.-C. Renauld, P. Staquet, J.-P. Vaerman, and Y. Sibille IL-9 Inhibits Oxidative Burst and TNF-{alpha} Release in Lipopolysaccharide-Stimulated Human Monocytes Through TGF-{beta} J. Immunol., April 15, 2002; 168(8): 4103 - 4111. [Abstract] [Full Text] [PDF]